Mon, Oct 20, 2014, 2:51 PM EDT - U.S. Markets close in 1 hr 9 mins

Recent

% | $
Quotes you view appear here for quick access.

Organovo Holdings, Inc. Message Board

  • pjcushing@alphagraphics.com pjcushing Apr 11, 2013 1:21 PM Flag

    Economist Article: Fit to Print: New ways to make living tissue artificially

    http://www.economist.com/news/science-and-technology/21575745-new-ways-make-living-tissue-artificially-fit-print

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • That's amazing.
      Dr Bayley’s paper describes not living cells, but synthetic printed material made to act like them. A cell is, in essence, a drop of watery liquid surrounded by a fatty membrane. Dr Bayley and his colleagues printed artificial versions of this arrangement: tiny droplets of an aqueous solution, each with a volume of a few trillionths of a litre, were sprayed into oil in order to pick up a fatty coat.

      On its own an individual droplet, even one with a fatty coating, is rather dull. Collectively, however, they become quite interesting. In one experiment, for example, Dr Bayley printed a pattern of droplets, some with proteins in their membranes. Each droplet’s coat bound to its neighbour’s to create a wall made up of two layers. The proteins formed pores in these walls and when the researchers applied a voltage, ions in the aqueous solution coursed through the pores, generating a signal similar to the “action potentials” that carry messages through nerve cells.

      Until now, those who have thought about printing artificial organs have assumed they would be made of real cells. Dr Bayley’s approach offers an alternative: artificial organs made of artificial cells. There would be an advantage to this, for such cells cannot reproduce and therefore could not become cancerous.

 
ONVO
6.17-0.04(-0.64%)2:50 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.